Literature DB >> 10632676

Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation.

R J Bischof1, D Zafiropoulos, J A Hamilton, I K Campbell.   

Abstract

CSF-1 and GM-CSF have been implicated in the pathogenesis of rheumatoid arthritis. We report the effects of CSF-1 and GM-CSF in the development of an acute methylated bovine serum albumin (mBSA)-induced murine arthritis model. Examination of histopathological features revealed that the systemic administration of CSF-1 or GM-CSF following mBSA administration into the knee resulted in the exacerbation of arthritis. This included synovial hyperplasia and joint inflammation, most evident at 7 and 14 days post-mBSA administration, and the appearance of erosive pannus tissue. The exacerbation by CSF-1 and GM-CSF was not sustained but declined in incidence and severity by 21 days post-mBSA administration, similar to the effects of IL-1beta in this model, reported here and previously. Macrophages expressing Mac-2 and F4/80 were a prominent feature of the pathology observed, particularly the infiltration of Mac-2+ macrophages seen in all mice administered CSF-1, GM-CSF or IL-1beta. Present in inflamed knees was a locally dividing population of cells which included Mac-2+ and F4/80+ macrophages. These studies demonstrate that CSF-1 and GM-CSF can exacerbate and prolong the histopathology of acute inflammatory arthritis and lend support to monocytes/macrophages being a driving influence in the pathogenesis of inflammatory arthritis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632676      PMCID: PMC1905504          DOI: 10.1046/j.1365-2249.2000.01125.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  How important are T cells in chronic rheumatoid synovitis?

Authors:  G S Firestein; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1990-06

2.  Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis.

Authors:  B P Hazenberg; M A Van Leeuwen; M H Van Rijswijk; A C Stern; E Vellenga
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

Review 3.  The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells.

Authors:  D Metcalf
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

4.  Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells.

Authors:  P J Morrissey; L Bressler; L S Park; A Alpert; S Gillis
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

5.  The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo.

Authors:  D A Hume; P Pavli; R E Donahue; I J Fidler
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

6.  Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.

Authors:  M K Ho; T A Springer
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

7.  Induction of an acute erosive monarticular arthritis in mice by interleukin-1 and methylated bovine serum albumin.

Authors:  N D Staite; K A Richard; D G Aspar; K A Franz; L A Galinet; C J Dunn
Journal:  Arthritis Rheum       Date:  1990-02

8.  Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.

Authors:  W D Xu; G S Firestein; R Taetle; K Kaushansky; N J Zvaifler
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice.

Authors:  I K Campbell; M J Rich; R J Bischof; A R Dunn; D Grail; J A Hamilton
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis.

Authors:  G S Firestein; W D Xu; K Townsend; D Broide; J Alvaro-Gracia; A Glasebrook; N J Zvaifler
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  30 in total

Review 1.  [New biologics and orally available compounds. What is still in the pipeline?].

Authors:  M Grünke; H Bastian; H Schulze-Koops; G-R Burmester
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

2.  Kruppel-like factor 2 (KLF2) regulates monocyte differentiation and functions in mBSA and IL-1β-induced arthritis.

Authors:  M Das; J Lu; M Joseph; R Aggarwal; S Kanji; B K McMichael; B S Lee; S Agarwal; A Ray-Chaudhury; O H Iwenofu; P Kuppusamy; V J Pompili; M K Jain; H Das
Journal:  Curr Mol Med       Date:  2012-02       Impact factor: 2.222

3.  Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts.

Authors:  Hiroyuki Eda; Hideaki Shimada; David R Beidler; Joseph B Monahan
Journal:  Rheumatol Int       Date:  2010-12-23       Impact factor: 2.631

Review 4.  Tyrosine kinases as targets for the treatment of rheumatoid arthritis.

Authors:  Christina D'Aura Swanson; Ricardo T Paniagua; Tamsin M Lindstrom; William H Robinson
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

Review 5.  Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage.

Authors:  Irina Ushach; Albert Zlotnik
Journal:  J Leukoc Biol       Date:  2016-06-28       Impact factor: 4.962

6.  Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.

Authors:  James G Conway; Brad McDonald; Janet Parham; Barry Keith; David W Rusnak; Eva Shaw; Marilyn Jansen; Peiyuan Lin; Alan Payne; Renae M Crosby; Jennifer H Johnson; Lloyd Frick; Min-Hwa Jasmine Lin; Scott Depee; Sarva Tadepalli; Bart Votta; Ian James; Karen Fuller; Timothy J Chambers; Frederick C Kull; Stanley D Chamberlain; Jeff T Hutchins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

7.  Multi-response model for rheumatoid arthritis based on delay differential equations in collagen-induced arthritic mice treated with an anti-GM-CSF antibody.

Authors:  Gilbert Koch; Thomas Wagner; Christine Plater-Zyberk; Gezim Lahu; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-23       Impact factor: 2.745

Review 8.  Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines.

Authors:  Ting-Wei Yu; Ho-Yen Chueh; Ching-Chou Tsai; Cheng-Tao Lin; Jiantai Timothy Qiu
Journal:  Hum Vaccin Immunother       Date:  2016-08-25       Impact factor: 3.452

Review 9.  Granulocyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor.

Authors:  Alejandro Francisco-Cruz; Miguel Aguilar-Santelises; Octavio Ramos-Espinosa; Dulce Mata-Espinosa; Brenda Marquina-Castillo; Jorge Barrios-Payan; Rogelio Hernandez-Pando
Journal:  Med Oncol       Date:  2013-11-22       Impact factor: 3.064

10.  The proliferative human monocyte subpopulation contains osteoclast precursors.

Authors:  Roya Lari; Peter D Kitchener; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2009-02-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.